HEALTHCARE PROVIDERS' PERCEPTIONS OF PRESCRIPTION MEDICATION SHARING AMONG ADULTS IN SAUDI ARABIA: A QUALITATIVE STUDY. (submitted in 2019)
5PSQ-077
PERCEPTIONS ABOUT PRESCRIPTION MEDICATION SHARING AMONG ADULTS IN SAUDI ARABIA: A QUALITATIVE STUDY.
5PSQ-076
PRESCRIPTION MEDICATION SHARING AMONG ADULTS IN SAUDI ARABIA: A CROSS-SECTIONAL SURVEY STUDY. (submitted in 2019)
5PSQ-075
SAFETY PROFILE OF FINGOLIMOD IN REAL WORLD CLINICAL PRACTICE: A PRELIMINARY STUDY (submitted in 2019)
5PSQ-074
FAMPRIDINE RELATED ATRIAL FIBRILLATION: TWO CASE REPORTS (submitted in 2019)
5PSQ-073
USEFULNESS OF SALIVA IN THERAPEUTIC DRUG MONITORING OF CAFFEINE IN PRETERM INFANTS (submitted in 2019)
5PSQ-072
ADEQUACY OF ANTIDEPRESSANT MEDICATION IN ELDERLY PATIENTS (submitted in 2019)
5PSQ-071
AN ADVERSE DRUG REACTION IN A PAEDIATRIC PATIENT WITH DRAVET SYNDROME: CANNABIDIOL AND VALPROATE DRUG-DRUG INTERACTION (submitted in 2019)
5PSQ-070
SAFETY STRATEGIES TO IMPROVE DRUG LABELLING IN OPERATING ROOMS (submitted in 2019)
5PSQ-069
CONCOMITANT PRESCRIPTION OF DRUGS FOR OSTEOPOROSIS AND MEDICATION THAT INCREASE THE OF RISK FALLS (submitted in 2019)
5PSQ-068
INCIDENCE OF FUNGAL INFECTIONS IN PATIENTS TREATED WITH IXEKIZUMAB (submitted in 2019)
5PSQ-067
SAFETY PROFILE OF PIRFENIDONE AND NINTEDANIB IN A REAL LIFE SETTING: ASSESSMENT OF SUSPECTED ADVERSE DRUG REACTIONS IN THE EMILIA ROMAGNA REGION, ITALY (submitted in 2019)
5PSQ-066
ANALYSIS OF POTENTIALLY INAPPROPRIATE MEDICATIONS IN ELDERLY ONCOLOGIC PATIENTS BY THE CHECK THE MEDS APP (submitted in 2019)
5PSQ-065
PREDICTION OF TOXICITY OF METHOTREXATE BY MEANS OF GENETIC TESTS IN PATIENTS DIAGNOSED WITH MODERATE-SEVERE PSORIASIS (submitted in 2019)
5PSQ-064
RELATED RISK OF BIOLOGIC DRUGS FOR CROHN’S DISEASE IN PREGNANCY: A CASE REPORT AND REVISION OF THE LITERATURE (submitted in 2019)
